Skip to main content

Want a detailed portfolio tracker?

Nautilus Biotechnology (NAUT) P/E (2021 - 2026)

Nautilus Biotechnology (NAUT) P/E from Jun 10, 2021 to Jul 21, 2026. The TTM Nautilus Biotechnology (NAUT) P/E is -3.77. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Nautilus Biotechnology (NAUT)

YearP/EChange
2026-3.77-9.73%
2025-4.18+40.07%
2024-2.98-52.06%
2023-6.22+69.81%
2022-3.66-58.14%
2021-8.75N/A

Comparison Nautilus Biotechnology (NAUT) P/E with competitors

Nautilus Biotechnology (NAUT) P/E is -3.77.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.00-100.11%
ENLVEnlivex Ltd0.07-101.98%
FGENFibroGen Inc0.24-106.37%
CHRSCoherus Biosciences Inc0.85-122.51%
FBIOFortress Biotech Inc0.95-125.18%
ORMPOramed Pharmaceuticals Inc1.50-139.88%
AGENAgenus Inc3.01-179.85%
INVAInnoviva Inc3.15-183.69%
VXRTVaxart Inc3.55-194.19%
CRMDCorMedix Inc3.63-196.27%
CVACCureVac N.V.4.45-217.96%
GLPGGalapagos NV4.86-228.92%
SRPTSarepta Therapeutics Inc4.88-229.54%
ABEOAbeona Therapeutics Inc5.39-242.95%
ABUSArbutus Biopharma Corp5.60-248.47%
ZVRAZevra Therapeutics Inc5.89-256.21%
SPROSpero Therapeutics Inc6.23-265.26%
CGENCompugen Ltd6.31-267.53%
RIGLRigel Pharmaceuticals6.87-282.34%
SLXNSilexion Therapeutics Corp7.30-293.59%
OMEROmeros Corporation9.26-345.66%
AUPHAurinia Pharmaceuticals Inc9.58-354.32%
PLXProtalix BioTherapeutics Inc10.89-388.97%
ACADAcadia Pharmaceuticals Inc11.73-411.19%
TBPHTheravance Biopharma Inc12.26-425.35%
ADMAAdma Biologics Inc12.42-429.49%
HRMYHarmony Biosciences Holdings Inc13.82-466.69%
SABSSAB Biotherapeutics Inc14.14-475.08%
INCYIncyte Corp15.82-519.82%
REGNRegeneron Pharmaceuticals Inc15.86-520.73%
PBYIPuma Biotechnology Inc17.32-559.44%
CPRXCatalyst Pharmaceuticals Inc17.44-562.72%
EXELExelixis Inc17.54-565.34%
TGTXTG Therapeutics Inc18.97-603.23%
MDXGMimedx Group Inc20.55-645.32%
XOMAXOMA Royalty Corp22.87-706.95%
ARGXArgen X SE24.30-744.72%
CTMXCytomX Therapeutics Inc24.82-758.60%
XOMAOXOMA Royalty Corp25.34-772.49%
HALOHalozyme Therapeutics Inc25.62-779.89%
XOMAPXOMA Royalty Corp25.67-781.13%
VRTXVertex Pharmaceuticals Inc27.99-842.81%
RPRXRoyalty Pharma plc - Class A28.69-861.19%
SLNOSoleno Therapeutics Inc29.02-869.89%
ASNDAscendis Pharma A/S30.09-898.28%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1105.95%
APLSApellis Pharmaceuticals Inc39.02-1135.38%
BMRNBiomarin Pharmaceutical Inc42.21-1220.04%
KRYSKrystal Biotech Inc45.34-1303.14%
ONCBeiGene Ltd69.54-1945.17%
PHARPharming Group N.V.75.03-2090.72%
TECHBio-Techne Corp101.96-2805.35%
VCELVericel Corp109.92-3016.63%
ALNYAlnylam Pharmaceuticals Inc117.96-3230.07%
GMABGenmab140.29-3822.45%
TLXTelix Pharmaceuticals Ltd162.15-4402.54%
CORTCorcept Therapeutics Inc212.86-5747.93%